Head-to-head · WeighScore
Healthicare vs Omada Health
The verdict
Healthicare takes it — 65.5/100 to 55.6/100.
Healthicare grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Healthicare is a GLP-1 telehealth platform offering both compounded options and a full brand-name menu — Ozempic, Wegovy, Mounjaro, and Zepbound — on a single account.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Healthicare | Omada Health |
|---|---|---|
| WeighScore | 65.5/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #216 | #435 |
| Semaglutide | $174/mo (compounded) | Not disclosed |
| Tirzepatide | $264/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #216 · C
Strengths
- Both compounded and full brand-name menu (Ozempic, Wegovy, Mounjaro, Zepbound) on one platform
- Pharmacy partner named publicly: Jungle Jim's Pharmacy (F&F Pharmacies Inc.), Fairfield, OH
- Clinical lead named publicly: Dr. Jonah Mink, Beluga Health
- Compounded semaglutide from $147.90/mo on the 3-month plan ($174/mo billed monthly) — lower end of the segment
Where it loses points
- Not available in several states including CA, NV, NJ, NC, TX, MA — verify your state first
- Brand-name first-month pricing of $1,199.99–$1,299.99 is at or above cash retail; value is on the compounded tier
- Footer references 'Sunshine Health Studios Inc.' — relationship to the domain owner is unclear
Graded #435 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.